PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2019788
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2019788
Blood Transfusion Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of blood transfusion diagnostics Market
The global blood transfusion diagnostics market is witnessing strong growth due to the rising demand for safe blood transfusion procedures and increasing prevalence of blood-related disorders. The market was valued at USD 5.70 billion in 2025 and is projected to reach USD 6.12 billion in 2026, further expanding to USD 11.25 billion by 2034. This steady growth reflects a CAGR of 7.90% during the forecast period. In 2025, North America dominated the market with a 39.71% share, driven by advanced healthcare infrastructure and high awareness of blood safety.
Blood transfusion diagnostics refers to a range of tests conducted on blood samples before transfusion to ensure compatibility between donor and recipient and to prevent the transmission of infectious diseases. These tests include blood grouping, antibody screening, and detection of transfusion-transmissible infections (TTIs). As transfusion therapy plays a vital role in surgeries, trauma care, and chronic disease management, the importance of accurate diagnostic procedures continues to grow globally.
Market Trends
One of the major trends shaping the market is the shift toward automated and molecular diagnostic platforms. Automation has significantly improved the accuracy, speed, and efficiency of blood testing processes. Technologies such as nucleic acid testing (NAT) and DG gel systems are increasingly being adopted to minimize human error and enhance reliability. These innovations allow laboratories and blood banks to streamline operations and improve patient safety, thereby boosting market growth.
Market Growth Drivers
The increasing demand for blood and blood components is a key factor driving market expansion. The rising prevalence of chronic diseases such as anemia, cancer, and kidney disorders has significantly increased the need for regular blood transfusions. Additionally, the growing number of surgical procedures, trauma cases, and childbirth-related complications further fuels the demand for blood diagnostics.
Another important growth factor is the rising awareness regarding blood safety. Governments, healthcare organizations, and NGOs are actively promoting safe blood donation practices and screening protocols. This has led to increased adoption of advanced diagnostic tools across hospitals, laboratories, and blood banks, thereby supporting market growth.
Restraining Factors
Despite strong growth prospects, the market faces certain challenges. The high cost of diagnostic instruments and testing kits is a major barrier, especially in developing regions. Additionally, limited healthcare infrastructure and a shortage of skilled professionals hinder the adoption of advanced diagnostic technologies. These factors restrict market growth in emerging economies where healthcare investments are comparatively low.
Segmentation Analysis
By product type, the reagents and kits segment dominates the market, accounting for 79.46% share in 2026, due to their recurring use in blood screening and typing procedures. The instruments segment holds a smaller share due to higher costs and longer lifecycle.
Based on application, the blood screening segment leads the market with a 69.06% share in 2026, driven by the increasing need to detect infectious diseases in donated blood. Blood group typing is also growing steadily due to rising demand for compatibility testing.
By end-user, independent laboratories and blood banks dominate with a 60.89% share in 2026, as they handle a large volume of blood testing procedures globally.
Regional Insights
North America remains the leading region, valued at USD 2.26 billion in 2025 and projected to reach USD 2.42 billion in 2026, supported by strong healthcare systems and high transfusion rates.
Europe held USD 1.61 billion in 2025, growing to USD 1.73 billion in 2026, driven by advanced diagnostic technologies and regulatory support.
Asia Pacific accounted for USD 1.31 billion in 2025 and is expected to reach USD 1.43 billion in 2026, witnessing the fastest growth due to rising population, increasing healthcare investments, and awareness programs.
Latin America and the Middle East & Africa show moderate growth, supported by improving healthcare access and untapped market opportunities.
Competitive Landscape
The market is highly competitive with key players such as Immucor, Inc., Grifols, S.A., Ortho Clinical Diagnostics, Abbott Laboratories, and F. Hoffmann-La Roche Ltd. These companies focus on product innovation, strong distribution networks, and strategic collaborations to strengthen their market presence.
Conclusion
In conclusion, the blood transfusion diagnostics market is set for substantial growth from USD 5.70 billion in 2025 to USD 11.25 billion by 2034, driven by rising healthcare needs, technological advancements, and increasing awareness of blood safety. While high costs and infrastructure limitations pose challenges, ongoing innovations and global health initiatives are expected to overcome these barriers. The market will continue to play a critical role in ensuring safe and efficient transfusion practices worldwide.
Growth Rate CAGR of 7.90% from 2026-2034
Segmentation By Product
- Instruments
- Kits & Reagents
By Application
- Blood Screening
- Blood Group Typing
By End-user
- Hospital-based Laboratories
- Independent Laboratories & Blood Banks
By Geography
- North America (By Product, By Application, By End-user, and By Country)
- U.S. (By Application)
- Canada (By Application)
- Europe (By Product, By Application, By End-user, and By Country/ Sub-region)
- U.K. (By Application)
- Germany (By Application)
- France (By Application)
- Italy (By Application)
- Spain (By Application)
- Scandinavia (By Application)
- Rest of Europe (By Application)
- Asia Pacific (By Product, By Application, By End-user, and By Country/ Sub-region)
- China (By Application)
- Japan (By Application)
- India (By Application)
- Australia (By Application)
- Southeast Asia (By Application)
- Rest of Asia Pacific (By Application)
- Latin America (By Product, By Application, By End-user, and By Country/ Sub-region)
- Brazil (By Application)
- Mexico (By Application)
- Rest of Latin America (By Application)
- Middle East & Africa (By Product, By Application, By End-user, and By Country/ Sub-region)
- GCC (By Application)
- South Africa (By Application)
- Rest of the Middle East & Africa (By Application)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Blood Donations Statistics, By Key Countries, 2025
- 4.2. Impact of COVID-19 on the Market
- 4.3. Prevalence of Key Bleeding Disorders, Key Regions/ Country, 2025
- 4.4. Blood Group Distribution Among Blood Donors in China
- 4.5. Distribution of Blood Group Type Among Indian & the U.S. Population
- 4.6. Blood Transfusion Statistics, 2025
- 4.7. Key Industry Developments- Mergers, Acquisitions, Partnerships, etc.
5. Global Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product
- 5.1.1. Instruments
- 5.1.2. Reagents & Kits
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Blood Screening
- 5.2.2. Blood Group Typing
- 5.3. Market Analysis, Insights and Forecast - By End-user
- 5.3.1. Hospital-based Laboratories
- 5.3.2. Independent Laboratories & Blood Banks
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product
- 6.1.1. Instruments
- 6.1.2. Reagents & Kits
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Blood Screening
- 6.2.2. Blood Group Typing
- 6.3. Market Analysis, Insights and Forecast - By End-user
- 6.3.1. Hospital-based Laboratories
- 6.3.2. Independent Laboratories & Blood Banks
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.1.1. By Application
- 6.4.2. Canada
- 6.4.2.1. By Application
- 6.4.1. U.S.
7. Europe Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product
- 7.1.1. Instruments
- 7.1.2. Reagents & Kits
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Blood Screening
- 7.2.2. Blood Group Typing
- 7.3. Market Analysis, Insights and Forecast - By End-user
- 7.3.1. Hospital-based Laboratories
- 7.3.2. Independent Laboratories & Blood Banks
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.4.1. U.K.
- 7.4.1.1. By Application
- 7.4.2. Germany
- 7.4.2.1. By Application
- 7.4.3. France
- 7.4.3.1. By Application
- 7.4.4. Spain
- 7.4.4.1. By Application
- 7.4.5. Italy
- 7.4.5.1. By Application
- 7.4.6. Scandinavia
- 7.4.6.1. By Application
- 7.4.7. Rest of Europe
- 7.4.7.1. By Application
- 7.4.1. U.K.
8. Asia Pacific Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product
- 8.1.1. Instruments
- 8.1.2. Reagents & Kits
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Blood Screening
- 8.2.2. Blood Group Typing
- 8.3. Market Analysis, Insights and Forecast - By End-user
- 8.3.1. Hospital-based Laboratories
- 8.3.2. Independent Laboratories & Blood Banks
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.4.1. Japan
- 8.4.1.1. By Application
- 8.4.2. China
- 8.4.2.1. By Application
- 8.4.3. India
- 8.4.3.1. By Application
- 8.4.4. Australia
- 8.4.4.1. By Application
- 8.4.5. Southeast Asia
- 8.4.5.1. By Application
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Application
- 8.4.1. Japan
9. Latin America Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product
- 9.1.1. Instruments
- 9.1.2. Reagents & Kits
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Blood Screening
- 9.2.2. Blood Group Typing
- 9.3. Market Analysis, Insights and Forecast - By End-user
- 9.3.1. Hospital-based Laboratories
- 9.3.2. Independent Laboratories & Blood Banks
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Application
- 9.4.2. Mexico
- 9.4.2.1. By Application
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Application
- 9.4.1. Brazil
10. Middle East & Africa Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product
- 10.1.1. Instruments
- 10.1.2. Reagents & Kits
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Blood Screening
- 10.2.2. Blood Group Typing
- 10.3. Market Analysis, Insights and Forecast - By End-user
- 10.3.1. Hospital-based Laboratories
- 10.3.2. Independent Laboratories & Blood Banks
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.4.1. GCC Countries
- 10.4.1.1. By Application
- 10.4.2. South Africa
- 10.4.2.1. By Application
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Application
- 10.4.1. GCC Countries
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Abbott
- 11.2.1.1. Overview
- 11.2.1.2. Products & Services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. F. Hoffmann-La Roche AG
- 11.2.2.1. Overview
- 11.2.2.2. Products & Services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Grifols, S.A.
- 11.2.3.1. Overview
- 11.2.3.2. Products & Services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Immucor, Inc.
- 11.2.4.1. Overview
- 11.2.4.2. Products & Services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Bio-Rad Laboratories, Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products & Services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Ortho Clinical Diagnostics
- 11.2.6.1. Overview
- 11.2.6.2. Products & Services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. QUOTIENT
- 11.2.7.1. Overview
- 11.2.7.2. Products & Services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Merck KGaA
- 11.2.8.1. Overview
- 11.2.8.2. Products & Services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.1. Abbott
List of Tables
- Table 1: Global Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 2: Global Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 3: Global Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 4: Global Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 5: North America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 6: North America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 7: North America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 8: North America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 9: U.S. Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 10: Canada Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 11: Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 12: Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 13: Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 14: Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 15: U.K. Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 16: Germany Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 17: France Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 18: Italy Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 19: Spain Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 20: Scandinavia Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 21: Rest of Europe Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 22: Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 23: Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 24: Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 25: Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 26: Japan Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 27: China Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 28: India Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 29: Australia Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 30: Rest of Asia Pacific Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 31: Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 32: Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 33: Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 34: Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 35: Brazil Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 36: Mexico Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 37: Rest of Latin America Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 38: Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Product, 2021-2034
- Table 39: Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 40: Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2021-2034
- Table 41: Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 42: GCC Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 43: South Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 44: Rest of Middle East & Africa Blood Transfusion Diagnostics Market Revenue (USD billion) Forecast, By Application, 2021-2034
List of Figures
- Figure 1: Global Blood Transfusion Diagnostics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025 & 2034
- Figure 3: Global Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025 & 2034
- Figure 4: Global Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025 & 2034
- Figure 5: Global Blood Transfusion Diagnostics Market Value (USD billion), by Region, 2025 & 2034
- Figure 6: North America Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 7: North America Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
- Figure 8: North America Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
- Figure 9: North America Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
- Figure 10: North America Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 11: North America Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
- Figure 12: North America Blood Transfusion Diagnostics Market Value (USD billion), By Country, 2025 & 2034
- Figure 13: North America Blood Transfusion Diagnostics Market Value Share (%), By Country, 2025
- Figure 14: Europe Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 15: Europe Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
- Figure 16: Europe Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
- Figure 17: Europe Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
- Figure 18: Europe Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 19: Europe Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
- Figure 20: Europe Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 21: Europe Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 22: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 23: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
- Figure 24: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
- Figure 25: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
- Figure 26: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 27: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
- Figure 28: Asia Pacific Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 30: Latin America Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 31: Latin America Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
- Figure 32: Latin America Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
- Figure 33: Latin America Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
- Figure 34: Latin America Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 35: Latin America Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
- Figure 36: Latin America Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 37: Latin America Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 38: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), by Product, 2025 & 2034
- Figure 39: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), by Product, 2025
- Figure 40: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), by Application, 2025 & 2034
- Figure 41: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), by Application, 2025
- Figure 42: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
- Figure 43: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), by End-user, 2025
- Figure 44: Middle East & Africa Blood Transfusion Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 45: Middle East & Africa Blood Transfusion Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 46: Global Blood Transfusion Diagnostics Market Share (%), By Company, 2025
